F-14/15, Orbit Mall, Civil Lines, Jaipur-302006
support@thetaxheaven.com
F-14/15, Orbit Mall, Civil Lines, Jaipur-302006 support@thetaxheaven.comRemedium Lifecare Ltd is a small-cap pharmaceutical and healthcare-related company that has seen significant volatility over the years. From its historical highs to recent consolidation near lower price levels, the stock has attracted attention from retail investors due to its low price, high delivery percentage, and potential turnaround expectations. With a focus on lifecare, pharma-related activities, and trading-linked operations, Remedium Lifecare Ltd remains a speculative but closely tracked counter in the micro-cap space.
In this article, we analyze Remedium Lifecare Ltd Share Price Target from 2026 to 2030 based on available market data, shareholding pattern, risk profile, and long-term outlook. The analysis is purely data-driven and focuses on possible scenarios rather than guarantees.
| Detail | Value |
|---|---|
| Open | ₹0.84 |
| Previous Close | ₹0.84 |
| Day’s High | ₹0.87 |
| Day’s Low | ₹0.84 |
| VWAP | ₹0.85 |
| Volume | 33,27,698 |
| Value (Lacs) | 28.29 |
| Market Capitalization | ₹74 Cr |
| Beta | 0.30 |
| UC Limit | ₹1.00 |
| LC Limit | ₹0.68 |
| 52-Week High | ₹4.28 |
| 52-Week Low | ₹0.80 |
| All-Time High | ₹31.35 |
| All-Time Low | ₹0.07 |
| Face Value | ₹1 |
| Book Value Per Share | ₹1.03 |
| 20D Avg Volume | 62,06,732 |
| 20D Avg Delivery (%) | 86.44% |
Remedium Lifecare Ltd operates in the healthcare and pharmaceutical-related segment. Over time, the company has gone through restructuring phases, price corrections, and changes in investor interest. Currently, the stock trades significantly below its book value, reflecting both market skepticism and potential recovery expectations.
The company is categorized as a micro-cap stock, which means price movements are often driven by liquidity, sentiment, and short- to medium-term triggers rather than consistent institutional participation.
Operates in the lifecare and healthcare-related space
Micro-cap structure with limited market capitalization
High delivery percentage indicating long-term holding interest
Trades below book value, suggesting undervaluation from a balance-sheet perspective
Low beta of 0.30 indicates relatively lower sensitivity to broader market swings
Highly retail-driven price action
Sharp contrast between historical highs and current trading range
| Investor Category | Holding (%) |
|---|---|
| Retail & Others | 98.87% |
| Promoters | 1.13% |
The extremely high retail participation shows that the stock is largely sentiment-driven. Low promoter holding is a risk factor, as it limits long-term confidence and strategic backing.
| Year | Minimum Target (₹) | Maximum Target (₹) |
|---|---|---|
| 2026 | 1.20 | 1.60 |
| 2027 | 1.50 | 2.10 |
| 2028 | 1.90 | 2.80 |
| 2029 | 2.40 | 3.50 |
| 2030 | 3.00 | 4.50 |
These projections consider gradual recovery, improved financial discipline, and stable market conditions. Being a micro-cap stock, outcomes may vary significantly based on execution and broader sentiment.
By 2026, the stock may stabilize above the ₹1 range if operational continuity improves and trading volumes remain healthy.
Growth Drivers
Price consolidation after long-term correction
High delivery percentage supporting accumulation
Potential restructuring or operational improvement
Investment View
Suitable only for high-risk investors with a speculative outlook.
In 2027, modest revenue visibility and improved disclosures could support gradual rerating.
Growth Drivers
Improved liquidity and participation
Market revaluation closer to book value
Possible expansion in healthcare-linked activities
Investment View
High-risk, medium-term opportunity for investors comfortable with volatility.
By 2028, sustained survival and consistency may help the stock attract renewed interest.
Growth Drivers
Stability in operations
Gradual improvement in investor confidence
Better alignment between price and fundamentals
Investment View
Only suitable for investors with patience and strong risk appetite.
As the healthcare sector continues to expand, Remedium Lifecare Ltd could benefit indirectly if execution improves.
Growth Drivers
Sector tailwinds
Reduction in speculative downside risk
Long-term accumulation by retail investors
Investment View
High-risk but potentially rewarding if the company sustains growth momentum.
By 2030, the stock may see a meaningful recovery if the company delivers consistency, transparency, and financial improvement.
Growth Drivers
Long-term survival and business continuity
Re-rating from extreme lows
Improvement in balance-sheet perception
Investment View
Speculative long-term bet with asymmetric risk-reward.
Remedium Lifecare Ltd is not a conventional long-term compounder. Instead, it represents a high-risk micro-cap opportunity where returns depend heavily on execution, transparency, and market sentiment.
Trading below book value
High delivery percentage indicating holding interest
Low beta compared to other penny stocks
Potential recovery from deeply corrected levels
Extremely low promoter holding
High dependence on retail sentiment
Limited publicly available financial clarity
High volatility and liquidity risk
Investors should monitor quarterly updates, corporate announcements, and volume trends before making allocation decisions.
Remedium Lifecare Ltd remains a high-risk, high-volatility micro-cap stock with recovery potential over the long term. While current prices reflect deep pessimism, sustained operational stability could gradually push the stock toward the ₹3 to ₹4.50 range by 2030. However, the journey is likely to be uneven and driven by sentiment as much as fundamentals.
This stock is suitable only for investors who clearly understand micro-cap risks and are prepared for sharp price swings.
It is trading around ₹0.84 as per the latest available market data.
The expected range for 2026 is ₹1.20 to ₹1.60.
The projected target range for 2030 is ₹3.00 to ₹4.50.
No, it is a high-risk micro-cap stock suitable only for speculative investors.
Low promoter holding, retail-heavy ownership, limited financial visibility, and high volatility.
Disclaimer: This article is for educational and informational purposes only. Stock market investments are subject to market risks. Please consult a certified financial advisor before making any investment decisions.
Register & Login